SEPTI-SOFT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Septi-soft, and when can generic versions of Septi-soft launch?
Septi-soft is a drug marketed by Calgon and is included in one NDA.
The generic ingredient in SEPTI-SOFT is hexachlorophene. There is one drug master file entry for this compound. Additional details are available on the hexachlorophene profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SEPTI-SOFT?
- What are the global sales for SEPTI-SOFT?
- What is Average Wholesale Price for SEPTI-SOFT?
Summary for SEPTI-SOFT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Patent Applications: | 4,580 |
| DailyMed Link: | SEPTI-SOFT at DailyMed |
US Patents and Regulatory Information for SEPTI-SOFT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calgon | SEPTI-SOFT | hexachlorophene | SOLUTION;TOPICAL | 017460-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
